Ex-US FDA official to lead Hong Kong’s new medical products regulator

A Beijing-educated former official at the US federal drug regulator has been appointed to lead Hong Kong’s new medical products approval body, tasked with accelerating the clinical use of medicines and medical devices as part of a regulatory overhaul. Dr Li Zili, who previously worked at the US Food and Drug Adminis…

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.